Mesco, ltd

About Mesco, ltd

We have been active primarily in three sectors:

Marketing Services, Media and Technology
Finance and Real Estate We have been retained in selective transactions which are complex, require intense focus and at times rely on international expertise Our mandates have included mergers and acquisitions, disposals, outright sales, joint ventures, licensing matters, distressed entities, restructuring and capital formation Mesco has the creativity and tract record to solve complex financial and capital challenges Our clients have benefited from our ability to be disciplined in critical negotiations and our goals to streamline and facilitate transactions Our experience and approach make transactions efficient, manageable and transparent to our partners and clients
In conjunction with Bank Sal Oppenheim jr
& Cie
(now wholly-owned by Deutsche Bank) structured this open-end healthcare fund in 1993
The Fund has ranged in size from $100 million to $600 million
Pharma/wHealth has delivered a net annual return of over 10
7% to its investors in the first 25 years of its existence
Historical performance, of course, is not a guaranty of future performance
We continue to provide advice regarding strategy, portfolio management, manager selection, marketing and reporting
Helped negotiate settlement with U
S
plaintiffs on behalf of Swiss shareholders
Advised in selecting the optimal banking team and the structuring and execution of $850 million global debt and equity financing
Advised in the sale of Centerpulse to Zimmer for CHF 4
8 billion in 2003
Sale resulted from first ever successful takeover bid in Switzerland
Transaction was named "The 2003 Healthcare Deal of the Year" by Investment Dealers Digest

(NY and Cambridge, MA - Private)

Advised this Life Science Strategy Consultancy on ownership options
Advised on global commercial and technology license arrangements
Advised on the sale of family owned business
Initiated, negotiated and closed sale

Private Equity Vehicle (European - Private)

Structured off-shore biotechnology private investment vehicle for wealthy family
Board of Directors (former) The healthcare related private equity investment activities by our clients, our affiliates and us include: » Pharma/wHealth - Europe » Amylin Pharmaceuticals, Inc

U S » Axxima Pharmaceuticals AG - Europe » Biota Holdings Limited - Australia » Cadus Pharmaceuticals, Inc
U S » Caliper Life Sciences - U S » Conceptis Technologies Inc
U S » Geneprot Inc
U S » Health Hero Network, Inc
U S » Lynx Therapeutics, Inc
U S » Memory Pharmaceuticals Corp
U S » Ontogeny, Inc
U S » Orchid BioSciences, Inc
U S » Peptimmune, Inc
U S » Physiome Sciences, Inc
U S » PrediX Pharmaceuticals, Inc
Israel » Precept Inc
U S » Signal Pharmaceuticals Inc
U S » Structural Genomix, Inc
U S » SWITCH Biotech AG - Europe » Tularik Inc
U S » Valentis lnc
U S